Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $239M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES | 880,000 | $44.59M | 18.6% | $27.77 | — | COM | 09627Y109 |
| AXGN | AXOGEN INC | 1,970,000 | $33M | 13.8% | $3.33 | +305.4% | COM | 05463X106 |
| — | FIBROGEN INC | 360,000 | $11.63M | 4.9% | $26.18 | — | COM | 31572Q808 |
| — | LOXO ONCOLOGY | 130,000 | $10.43M | 4.4% | $27.48 | — | COM | 548862101 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,180,000 | $8.437M | 3.5% | $2.44 | — | COM | G85347105 |
| CDXS | CODEXIS INC | 1,470,000 | $8.011M | 3.3% | $2.52 | +82.8% | COM | 192005106 |
| — | IMMUNOMEDICS INC | 900,000 | $7.947M | 3.3% | $6.47 | — | COM | 452907108 |
| — | MOMENTA PHARMACEUTICALS INC | 450,000 | $7.605M | 3.2% | $14.68 | — | COM | 60877T100 |
| TBPH | THERAVANCE BIOPHARMA INC | 180,000 | $7.171M | 3.0% | $31.13 | +23.5% | COM | G8807B106 |
| CTMX | CYTOMX THERAPEUTICS INC | 460,000 | $7.13M | 3.0% | $13.03 | +15.7% | COM | 23284F105 |
| — | CHIMERIX INC | 1,280,000 | $6.976M | 2.9% | $5.05 | — | COM | 16934W106 |
| — | NOVELION THERAPEUTICS INC | 750,000 | $6.922M | 2.9% | $10.70 | — | COM NEW | 67001K202 |
| AGIO | AGIOS PHARMACEUTICALS | 130,000 | $6.688M | 2.8% | $43.03 | +18.8% | COM | 00847X104 |
| — | CORIUM INTERNATIONAL INC | 715,000 | $5.334M | 2.2% | $7.54 | — | COM | 21887L107 |
| — | FOAMIX PHARMACEUTICALS LTD | 1,135,000 | $5.266M | 2.2% | $5.96 | — | SHS | M46135105 |
| SGMO | SANGAMO BIOSCIENCES INC | 580,000 | $5.104M | 2.1% | $3.76 | +70.8% | COM | 800677106 |
| — | ADAMAS PHARMACEUTICALS INC | 290,000 | $5.072M | 2.1% | $18.61 | — | COM | 00548A106 |
| EGRX | EAGLE PHARMACEUTICALS INC | 60,000 | $4.733M | 2.0% | $69.67 | +17.4% | COM | 269796108 |
| PRTA | PROTHENA CORP PLC | 85,000 | $4.6M | 1.9% | $54.16 | -1.6% | SHS | G72800108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 100,000 | $3.598M | 1.5% | $28.91 | +10.6% | COM | 29251M106 |
| — | NEURODERM LTD | 120,300 | $3.597M | 1.5% | $16.69 | — | ORD SHS | M74231107 |
| — | ACCELERON PHARMA INC | 100,000 | $3.039M | 1.3% | $30.39 | — | COM | 00434H108 |
| — | AUDENTES THERAPEUTICS INC | 150,000 | $2.869M | 1.2% | $19.13 | — | COM | 05070R104 |
| — | IMPRIMIS PHARMACEUTICALS INC | 895,000 | $2.864M | 1.2% | $2371.00 | — | COM NEW | 45323A201 |
| ARDX | ARDELYX | 546,500 | $2.787M | 1.2% | $8.48 | 0.0% | COM | 039697107 |
| — | TETRAPHASE PHARMACEUTICALS I | 330,000 | $2.353M | 1.0% | $7.13 | — | COM | 88165N105 |
| WVE | WAVE LIFE SCIENCES LTD | 125,000 | $2.325M | 1.0% | $25.55 | -15.6% | SHS | Y95308105 |
| — | ARATANA THERAPEUTICS INC | 350,200 | $2.279M | 1.0% | $6.51 | — | COM | 03874P101 |
| XOMA | XOMA CORP DEL | 317,200 | $2.217M | 0.9% | $6.46 | +3.0% | COM NEW | 98419J206 |
| — | MIRNA THERAPEUTICS INC | 1,148,100 | $1.917M | 0.8% | $1.67 | — | COM | 60470J103 |
| — | SYROS PHARMACEUTICALS INC | 109,500 | $1.762M | 0.7% | $16.05 | — | COM | 87184Q107 |
| — | ZOSANO PHARMA CORP | 1,225,000 | $1.727M | 0.7% | $1.90 | — | COM | 98979H103 |
| — | TONIX PHARMACEUTICALS HOLDING | 370,000 | $1.602M | 0.7% | $4.54 | — | COM NEW | 890260201 |
| — | PROTALIX BIOTHERAPEUTICS INC | 1,835,000 | $1.537M | 0.6% | $1.32 | — | COM | 74365AAB7 |
| — | EDGE THERAPEUTICS INC | 130,000 | $1.334M | 0.6% | $9.54 | — | COM | 279870109 |
| — | ARQULE INC | 970,000 | $1.203M | 0.5% | $1.14 | — | COM | 04269E107 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 40,000 | $1.094M | 0.5% | $27.35 | — | COM | 37890U108 |
| — | INTRA CELLULAR THERAPIES INC | 85,000 | $1.056M | 0.4% | $12.42 | — | COM | 04611X101 |
| — | SUNESIS PHARMACEUTICALS INC | 380,000 | $1.026M | 0.4% | $4.10 | — | COM PAR | 867328700 |
| — | NEOS THERAPEUTICS INC | 50,000 | $365K | 0.2% | $7.30 | — | COM | 64052L106 |
| — | BIOLINERX LTD | 250,000 | $212K | 0.1% | $1426.15 | — | SPONSORED ADR | 09071M106 |